Committee Members at World Pharma Conference 2024

Organizing Committee Members

View Profile

Kalliopi Megari

Aristotle University of Thessaloniki, Greece

Profile

Kalliopi Megari

Aristotle University of Thessaloniki, Greece

Dr. Kalliopi Megari is an experienced neuropsychologist working in the hospital & health care industry. Skilled in Clinical Neuropsychology, Clinical Research and Learning Disabilities. Graduated from Aristotle University of Thessaloniki and attended further education from University of Macedonia, in people with special needs and disabilities. She holds undergraduate degrees in Nursing and Psychology, as well as a Masters and a PhD in Neuropsychology from Aristotle University of Thessaloniki. She has many years of experience working with cancer and cardiac surgery patients as well with people with disabilities. She is postdoctoral researcher she has many research articles and participated in many international conferences. Her work has earned her many prestigious international awards. She has given lectures at Aristotle University of Thessaloniki and University of Warsaw. She is the Global Engagement Representative of International Neuropsychological Society and General Secretary and member of the Ethics Committee of Hellenic Neuropsychological Society.

View Profile

Wilko Coers

MD of Meducom: Tailored top-Q medical education and communication, Netherlands

Profile

Wilko Coers

MD of Meducom: Tailored top-Q medical education and communication, Netherlands

Mr Wilko Coers is managing Director of Meducom:Tailored top-Q medical education and communication Amsterdam, Netherlands. He did PhD in medicine. He worked as an Investigator at UMCG (1994-1998), Clinical Research Manager at Merck Sharp & Dohme, (1998-2001) Senior Medical Advisor at Excerpta Medica (2001-2005). He having more than 25 years of experience medicine field. Meducom BV (The Netherlands) provides tailored top-quality services in medical education and medical communication. Our clients range from healthcare and insurance companies to (international) pharma and medical devices companies.

View Profile

Mihail Lucian Birsa

Professor at "Alexandru Ioan Cuza" University of Iasi, Romania

Profile

Mihail Lucian Birsa

Professor at "Alexandru Ioan Cuza" University of Iasi, Romania

Dr. Mihail Lucian Birsa is currently a Professor in the Department of Chemistry at the Alexandru Ioan Cuza University of Iasi, Romania. In 2003 he was selected as a member of the Alexander von Humboldt Foundation, working with Professor Henning Hopf in TU Braunschweig - Germany. Since then numerous return fellowships were granted by the Alexander von Humboldt Foundation. He has more than 120 publications in peer-review journals and published +45 books/book chapters (John Wiley & Sons, Thieme etc). Also, is editorial board member in more than 50 journals.

View Profile

Laura Gabriela SARBU

Professor at "Alexandru Ioan Cuza" University of Iasi, Romania

Profile

Laura Gabriela SARBU

Professor at "Alexandru Ioan Cuza" University of Iasi, Romania

Dr. Laura Gabriela SARBU is currently an Associate Professor in the Department of Chemistry at Alexandru Ioan Cuza University of Iasi, Romania. She received a Ph.D. degree in Organic Chemistry in 2015. During the Ph.D. program she joined several times the Prof. dr. Henning Hopf research team in TU Braunschweig – Germany. She has more than 40 publications in peer-review journals and published 4 books. Also, is editorial board member in 25+ journals.

View Profile

Orestis Ioannidis

Surgeon at General Hospital "George Papanikolaou", Thessaloniki, Greece

Profile

Orestis Ioannidis

Surgeon at General Hospital "George Papanikolaou", Thessaloniki, Greece

Dr. Ioannidis studied medicine in the Aristotle University of Thessaloniki and graduated at 2005. He received his MSC in “Medical Research Methodology” in 2008 from Aristotle University of Thessaloniki and in “Surgery of Liver, Biliary Tree and Pancreas” from the Democritus University of Thrace in 2016. He received his PhD degree in 2014 from the Aristotle University of Thessaloniki for his thesis “The effect of combined administration of omega-3 and omega-6 fatty acids in ulcerative colitis. Experimental study in rats.” He is a General Surgeon with special interest in laparoscopic surgery and surgical oncology and also in surgical infections, acute care surgery, nutrition and ERAS. He has received fellowships for EAES, ESSO, EPC, ESCP and ACS and has published more than 130 articles with more than 3000 citations and an H-index of 28.

View Profile

Raghuram Selvaraju

MD of Equity Research at H.C. Wainwright & Chairman of the Board at Relief Therapeutics Holding AG

Profile

Raghuram Selvaraju

MD of Equity Research at H.C. Wainwright & Chairman of the Board at Relief Therapeutics Holding AG

Dr. Raghuram Selvaraju is a Managing Director of Equity Research at H.C. Wainwright - a full-service investment bank headquartered in New York City - whose research focuses on the healthcare sector, particularly pharmaceutical and biotechnology companies and programs. He is also Chairman of the Board at Relief Therapeutics Holding AG, a publicly-listed commercial-stage biopharmaceutical company headquartered in Geneva, Switzerland. Dr. Selvaraju possesses over a decade’s worth of experience in Healthcare Equity Research. In 2021, Dr. Selvaraju was the top analyst in the world across all sectors according to TipRanks based on portfolio return. Dr. Selvaraju was ranked by both StarMine for his earnings accuracy and by The Wall Street Journal’s annual Best on the Street survey for his stock-picking performance. In addition, Dr. Selvaraju has appeared numerous times on Bloomberg, CNBC, Business News Network and BTV where he has extensively discussed drug development trends, healthcare reform policy, and pharma/biotech M&A. Prior to joining H.C. Wainwright, Dr. Selvaraju held Senior Research positions at MLV & Co., Aegis Capital, Hapoalim Securities USA (the U.S. broker/dealer arm of Bank Hapoalim B.M., Israel’s largest financial services group) and Rodman & Renshaw LLC. He was Head of Healthcare Equity Research at both Aegis Capital and Hapoalim Securities and established the equity research division at Aegis Capital. Dr. Selvaraju’s educational background includes a Ph.D. in molecular neuroscience and cellular immunology, an M.S. degree in molecular biology from the University of Geneva in Switzerland, and an MBA from the Johnson Graduate School of Management at Cornell University. He obtained a B.S. degree from Carnegie Mellon University in Pittsburgh, PA with a dual major in cell, molecular and developmental biology and technical writing.

View Profile

Ralf Aubeck

Principal Consultant and Industry Certified GMP Auditor at Gempex GmbH, Germany

Profile

Ralf Aubeck

Principal Consultant and Industry Certified GMP Auditor at Gempex GmbH, Germany

Ralph Aubeck works worldwide for Gempex GmbH as Principal Consultant and Industry Certified GMP Auditor. He studied chemistry at the Ludwig-Maximilians-University in Munich and received his PhD in 1991. re. of course via chemical-pharmaceutical biosensors. More than 28 years of experience in responsible positions in quality management in German and American small and medium-sized industrial companies as well as large corporations in Germany and Switzerland form the foundation of his practical expertise.

View Profile

Gamal Heiba

Commercial Director at GSK, Egypt

Profile

Gamal Heiba

Commercial Director at GSK, Egypt

Dr Gamal Heiba is currently working as a Commercial Director at GSK since last 21 years. He received master degree from Eslesca Business School in the year of 2011 & Bachelor's degree in Medical Sciences and Veterinary Medicine from Cairo University in the year of 1983 – 1989. He worked as a Lieutenant Officer in Egyptian Military Force from Oct 1989 - Dec 1991, He having work experience in Bayer & GSK companies.

View Profile

Miloš Milenković

Strategic Partnering Chapter Head & CEETRIS region Established Products Lead at Roche, Serbia

Profile

Miloš Milenković

Strategic Partnering Chapter Head & CEETRIS region Established Products Lead at Roche, Serbia

Mr Miloš Milenković is currently working as a Strategic Partnering Chapter Head & CEETRIS region Established Products Lead at Roche, Serbia. He also worked as a Commercial Affairs Lead in Turkey, Strategic Partnership Lead, Commercial and Partnering, Head Business Development & Commercial Manager in Roche & GlaxoSmithKline (GSK). He having more than 20 years of experience in Pharma industries. He is graduate in pharmacy & post graduate in MBA from Frankfurt School of Finance and Management, Frankfurt, Germany.

View Profile

Marco Penske

Head Market Access & Healthcare Affairs Boehringer Ingelheim, Germany

Profile

Marco Penske

Head Market Access & Healthcare Affairs Boehringer Ingelheim, Germany

Dr Marco Penske has been the Head of Market Access and Healthcare Affairs at Boehringer Ingelheim since 2011. Dr Penske studied Economics at Johannes Gutenberg University Mainz, focussing on Health Economics and Statistics. Afterwards, he worked as a research assistant for the chair of Finance and Economics at the university. Following his promotion in the field of healthcare systems, he was employed at a business consultancy company. In 2007, he joined Boehringer Ingelheim and gained experience within several Market Access functions. In his current role, he is responsible for benefit assessments and price negotiation in accordance with AMNOG, developing pricing strategies and contract models for pharmaceuticals, health economics and outcomes research as well as key account management and healthcare affairs activities. In addition, he is an active speaker at congresses and works as a lecturer.

Committee Members

Organizing Committee Members

Kalliopi Megari

Wilko Coers

Mihail Lucian Birsa

Laura Gabriela SARBU

Orestis Ioannidis

Raghuram Selvaraju

Ralf Aubeck

Gamal Heiba

Miloš Milenković

Marco Penske

About The People Event.

Quick Links

More Info